CytomX Therapeutics Announces Full-Year 2018 Financial Results

Go back to CytomX Therapeutics Announces Full-Year 2018 Financial Results
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 2.76 --0 (-0%)
Previous Close $2.76    52 Week High $24.68 
Open $2.80    52 Week Low $9.10 
Day High $2.83    P/E N/A 
Day Low $2.74    EPS $0.00 
Volume 2,330,496